- EStimME was chosen after presenting initial results of its clinical study at EuroMedtech 2011 -

Tel – Aviv, Israel,  July 20th, 2011 – EStimME (a RAD Biomed Accelerator  portfolio company) has been chosen as hot pick of the month in the July issue of Clinica (http://www.clinica.co.uk/multimedia/archive/00161/MTV_52_161998a.pdf) , a leading publication covering  the international devices and diagnostics industries. EStimME previously presented its technology at EuroMedtech 2011, which was held in Turin, Italy from the 16^th to the 17^th of May, 2011. (http://www.ebdgroup.com/emt/index.php).

-- Eon Surgical’s InterTip^TM Platform will be featured in the “Amazing Technologies” session --

Tel – Aviv, Israel,  June 5th, 2011 – Eon Surgical (a RAD Biomed Accelerator  portfolio company) announced today that it has been invited to present at the “Amazing Technologies” session  in the 19th International Congress of the European Association for Endoscopic Surgery (EAES), which will be held in Torino, Italy from the 15th to the 18th of June, 2011. (http://congress.eaes.eu/congress2011.aspx). Dr. Yoav Mintz, Director of the Department of General Surgery in Hadassah-University Medical Center in Jerusalem, will present at EAES the first full pre-clinical procedure to be conducted with the InterTip^TM.

-- Discover Medical Devices’ SomnuSeal Mask is Breakthrough Product for Patients with Obstructive Sleep Apnea  --

Tel – Aviv, Israel, March 21^st,  2011 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that its portfolio company, Discover Medical Devices, has started a second clinical trial for its Somnuseal™ mask for patients with Obstructive Sleep Apnea (OSA)

-- Softwheel  will develop breakthrough solutions in assistive technology aimed at wheelchair users --

Tel – Aviv, Israel, February 17^th,  2011 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that  it has added Softwheel, a new medical device company, to its portfolio. Softwheel will develop a breakthrough technology aimed at wheelchair users.

Tel – Aviv, Israel, February 16^th,  2011 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that  its portfolio company EstimME has been featured as "Start-Up of  the Week", by Globes – Israel's leading business daily newspaper. EstimME is developing a minimally invasive device for the treatment of tinnitus. The article (in Hebrew) can be downloaded here (link).

-- Plexicure is a joint venture between RAD BioMed, Israeli vernture capital Pontifax and Roche Pharmaceuticals --

Tel – Aviv, Israel, January 1^st,  2011 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that  it has added Plexicure, a new biopharma company that will be developed as a joint venture with Israeli venture capital firm Pontifax , in partnership with Roche AG (SWX: RO).

-- Dr.  Kremer Tal joins RAD BioMed from Novartis US --

Tel – Aviv, Israel, December 1^st,  2010 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that  Dr. Sigal Kremer-Tal, MD has joined its top management team as the new VP Scouting & Operations. 

-- VGS to show the latest preclinical results for its FLUENT device  --

Tel  Aviv, Israel, September 21^st,  2010 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that its portfolio company, Vascular Graft Solutions (VGS), has been invited to present this year’s TCT  (Transcatheter Cardiovascular Therapeutics) conference in Washington DC.

-- The financing round was led by Israeli venture capital firm Coronis Partners --

Tel – Aviv, Israel, May 2^nd,  2010 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that  its portfolio company AOPharma has successfully completed a $2 million investment round raised from investors including Coronis Partners – an Investment Company specialized in the Biotechnology sector, Mr. Gur Munzer, owner of Care Medical Services and of Natali and RAD BioMed Accelerator.